Ievgen Koliesnik
Stanford University
H-index: 9
North America-United States
Top articles of Ievgen Koliesnik
Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue
Nature Communications
2024/2/20
STK-012, an a/b-selective IL-2 activates tumor antigen specific CD25+ CD8 T cells to reject tumors without acute vascular toxicity
Cancer Research
2023/4/4
Novel IL-12 Partial Agonist For Cancer Immunotherapy Avoids NK-cell Mediated Toxicity
Cancer Research
2023/4/4
Ievgen Koliesnik
H-Index: 4
FOXP3+ regulatory T cells use heparanase to access IL-2 bound to ECM in inflamed tissues
bioRxiv
2023/2/27
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist
Elife
2021/5/18
Humanized mouse models for the advancement of innate lymphoid cell-based cancer immunotherapies
Advances in Human Immune System (HIS) Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy
2022/2/10
Treatment with a neutrophil elastase inhibitor and ofloxacin reduces P. aeruginosa burden in a mouse model of chronic suppurative otitis media
npj Biofilms and Microbiomes
2021/4/6
Acknowledgment to Reviewers of Animals in 2020
Animals: an Open Access Journal from MDPI
2021/2
Author response: Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist
eLife
2021
Correction: Dietary restriction improves repopulation but impairs lymphoid differentiation capacity of hematopoietic stem cells in early aging
Journal of Experimental Medicine
2020/12/17
Identification of undescribed Relb expression domains in the murine brain by new Relb:cre‐katushka reporter mice
Developmental Dynamics
2020/8
Ievgen Koliesnik
H-Index: 4
The heparan sulfate mimetic PG545 modulates T cell responses and prevents delayed-type hypersensitivity
Frontiers in Immunology
2020/2/6
